United States · FDA National Drug Code directory
Orenitram
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66302-300_bd66c62e-4aee-4fd0-bc7d-f78994dd9e29
- Product NDC
- 66302-300
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- treprostinil
- Labeler
- United Therapeutics Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20131220
- Source listing expiry
- 20261231
Source-listed ingredients
- TREPROSTINIL — .125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (66302-300-01) · 66302-300-01
- 1 BLISTER PACK in 1 CARTON (66302-300-02) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 66302-300-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →